nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0744	0.319	CbGbCtD
Amsacrine—CYP2D6—Cholecalciferol—osteoporosis	0.056	0.241	CbGbCtD
Amsacrine—ABCB1—Conjugated Estrogens—osteoporosis	0.0546	0.234	CbGbCtD
Amsacrine—ABCB1—Estradiol—osteoporosis	0.0479	0.206	CbGbCtD
Amsacrine—NCOA3—Validated nuclear estrogen receptor beta network—ESR2—osteoporosis	0.012	0.0897	CbGpPWpGaD
Amsacrine—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00782	0.0582	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—PARK7—osteoporosis	0.00703	0.0524	CbGpPWpGaD
Amsacrine—NCOA3—Retinoic acid receptors-mediated signaling—VDR—osteoporosis	0.00549	0.0409	CbGpPWpGaD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—GPD2—osteoporosis	0.00471	0.0351	CbGpPWpGaD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—WNT1—osteoporosis	0.00426	0.0318	CbGpPWpGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—ESR2—osteoporosis	0.00377	0.0281	CbGpPWpGaD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—osteoporosis	0.00366	0.0273	CbGpPWpGaD
Amsacrine—TOP2A—Fulvestrant—Estradiol—osteoporosis	0.00342	0.337	CbGdCrCtD
Amsacrine—TOP2A—Circadian rythm related genes—ID4—osteoporosis	0.00329	0.0245	CbGpPWpGaD
Amsacrine—NCOA3—FOXA1 transcription factor network—ESR1—osteoporosis	0.00309	0.023	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.00267	0.0199	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—RAP1A—osteoporosis	0.00252	0.0188	CbGpPWpGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—ESR1—osteoporosis	0.00229	0.017	CbGpPWpGaD
Amsacrine—TOP2A—Levorphanol—Estradiol—osteoporosis	0.00226	0.222	CbGdCrCtD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—LEP—osteoporosis	0.00207	0.0154	CbGpPWpGaD
Amsacrine—TOP2A—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.00206	0.203	CbGdCrCtD
Amsacrine—NCOA3—Developmental Biology—CAP1—osteoporosis	0.002	0.0149	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00198	0.0147	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00188	0.014	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	0.00172	0.0128	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—osteoporosis	0.00168	0.0125	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.0016	0.0119	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.00146	0.0109	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00142	0.0106	CbGpPWpGaD
Amsacrine—TOP2A—Norethindrone—Ethinyl Estradiol—osteoporosis	0.00135	0.132	CbGdCrCtD
Amsacrine—NCOA3—Developmental Biology—TLN1—osteoporosis	0.00125	0.00934	CbGpPWpGaD
Amsacrine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00125	0.0093	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—ACTG1—osteoporosis	0.00124	0.00922	CbGpPWpGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—MYC—osteoporosis	0.00119	0.00887	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—ESR1—osteoporosis	0.00115	0.00858	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.00114	0.00846	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00113	0.00842	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.00112	0.00832	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—IRS1—osteoporosis	0.00108	0.00802	CbGpPWpGaD
Amsacrine—TOP2A—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00107	0.105	CbGdCrCtD
Amsacrine—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00104	0.00167	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00104	0.00166	CcSEcCtD
Amsacrine—Decreased appetite—Ibandronate—osteoporosis	0.00103	0.00166	CcSEcCtD
Amsacrine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00103	0.00165	CcSEcCtD
Amsacrine—Infestation NOS—Estradiol—osteoporosis	0.00103	0.00165	CcSEcCtD
Amsacrine—Infestation—Estradiol—osteoporosis	0.00103	0.00165	CcSEcCtD
Amsacrine—Pain—Raloxifene—osteoporosis	0.00103	0.00165	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00103	0.00165	CcSEcCtD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoporosis	0.00102	0.00763	CbGpPWpGaD
Amsacrine—Fatigue—Ibandronate—osteoporosis	0.00102	0.00164	CcSEcCtD
Amsacrine—Leukopenia—Pamidronate—osteoporosis	0.00102	0.00164	CcSEcCtD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.00102	0.00759	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.00102	0.00759	CbGpPWpGaD
Amsacrine—Alopecia—Conjugated Estrogens—osteoporosis	0.00102	0.00163	CcSEcCtD
Amsacrine—Pain—Ibandronate—osteoporosis	0.00102	0.00163	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00101	0.00163	CcSEcCtD
Amsacrine—Gastrointestinal pain—Estropipate—osteoporosis	0.00101	0.00163	CcSEcCtD
Amsacrine—Decreased appetite—Calcitriol—osteoporosis	0.00101	0.00162	CcSEcCtD
Amsacrine—Mental disorder—Conjugated Estrogens—osteoporosis	0.00101	0.00162	CcSEcCtD
Amsacrine—Feeling abnormal—Alendronate—osteoporosis	0.00101	0.00161	CcSEcCtD
Amsacrine—Malnutrition—Conjugated Estrogens—osteoporosis	0.001	0.00161	CcSEcCtD
Amsacrine—Jaundice—Estradiol—osteoporosis	0.001	0.00161	CcSEcCtD
Amsacrine—Gastrointestinal pain—Alendronate—osteoporosis	0.000998	0.0016	CcSEcCtD
Amsacrine—Infection—Ethinyl Estradiol—osteoporosis	0.000997	0.0016	CcSEcCtD
Amsacrine—Pain—Calcitriol—osteoporosis	0.000994	0.0016	CcSEcCtD
Amsacrine—Convulsion—Pamidronate—osteoporosis	0.000988	0.00159	CcSEcCtD
Amsacrine—Urticaria—Estropipate—osteoporosis	0.000984	0.00158	CcSEcCtD
Amsacrine—Vision blurred—Zoledronate—osteoporosis	0.000982	0.00158	CcSEcCtD
Amsacrine—Gastrointestinal pain—Raloxifene—osteoporosis	0.000981	0.00158	CcSEcCtD
Amsacrine—Diarrhoea—Etidronic acid—osteoporosis	0.00098	0.00157	CcSEcCtD
Amsacrine—Haematuria—Estradiol—osteoporosis	0.000979	0.00157	CcSEcCtD
Amsacrine—Body temperature increased—Estropipate—osteoporosis	0.000979	0.00157	CcSEcCtD
Amsacrine—Abdominal pain—Estropipate—osteoporosis	0.000979	0.00157	CcSEcCtD
Amsacrine—Feeling abnormal—Ibandronate—osteoporosis	0.000979	0.00157	CcSEcCtD
Amsacrine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000975	0.00157	CcSEcCtD
Amsacrine—Infection—Risedronate—osteoporosis	0.000972	0.00156	CcSEcCtD
Amsacrine—Hepatobiliary disease—Estradiol—osteoporosis	0.000971	0.00156	CcSEcCtD
Amsacrine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000971	0.00156	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00097	0.00722	CbGpPWpGaD
Amsacrine—Urticaria—Alendronate—osteoporosis	0.000969	0.00156	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000966	0.00719	CbGpPWpGaD
Amsacrine—Body temperature increased—Alendronate—osteoporosis	0.000964	0.00155	CcSEcCtD
Amsacrine—Abdominal pain—Alendronate—osteoporosis	0.000964	0.00155	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—WNT1—osteoporosis	0.000964	0.00718	CbGpPWpGaD
Amsacrine—Anaemia—Zoledronate—osteoporosis	0.000963	0.00155	CcSEcCtD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—TNF—osteoporosis	0.000957	0.00712	CbGpPWpGaD
Amsacrine—Skin disorder—Risedronate—osteoporosis	0.000951	0.00153	CcSEcCtD
Amsacrine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000951	0.00153	CcSEcCtD
Amsacrine—Abdominal pain—Raloxifene—osteoporosis	0.000948	0.00152	CcSEcCtD
Amsacrine—Body temperature increased—Raloxifene—osteoporosis	0.000948	0.00152	CcSEcCtD
Amsacrine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000945	0.00152	CcSEcCtD
Amsacrine—Urticaria—Ibandronate—osteoporosis	0.000944	0.00152	CcSEcCtD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—osteoporosis	0.000943	0.00702	CbGpPWpGaD
Amsacrine—Body temperature increased—Ibandronate—osteoporosis	0.000939	0.00151	CcSEcCtD
Amsacrine—Abdominal pain—Ibandronate—osteoporosis	0.000939	0.00151	CcSEcCtD
Amsacrine—Confusional state—Pamidronate—osteoporosis	0.000938	0.00151	CcSEcCtD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000935	0.00696	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—MYC—osteoporosis	0.000932	0.00694	CbGpPWpGaD
Amsacrine—Leukopenia—Zoledronate—osteoporosis	0.000932	0.0015	CcSEcCtD
Amsacrine—Haemoglobin—Estradiol—osteoporosis	0.000927	0.00149	CcSEcCtD
Amsacrine—Infection—Pamidronate—osteoporosis	0.000924	0.00148	CcSEcCtD
Amsacrine—Urticaria—Calcitriol—osteoporosis	0.000924	0.00148	CcSEcCtD
Amsacrine—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000922	0.00687	CbGpPWpGaD
Amsacrine—Hepatitis—Estradiol—osteoporosis	0.000922	0.00148	CcSEcCtD
Amsacrine—Haemorrhage—Estradiol—osteoporosis	0.000922	0.00148	CcSEcCtD
Amsacrine—Body temperature increased—Calcitriol—osteoporosis	0.000919	0.00148	CcSEcCtD
Amsacrine—Abdominal pain—Calcitriol—osteoporosis	0.000919	0.00148	CcSEcCtD
Amsacrine—Hypoaesthesia—Estradiol—osteoporosis	0.000917	0.00147	CcSEcCtD
Amsacrine—Hypersensitivity—Estropipate—osteoporosis	0.000913	0.00147	CcSEcCtD
Amsacrine—Thrombocytopenia—Pamidronate—osteoporosis	0.000911	0.00146	CcSEcCtD
Amsacrine—Urinary tract disorder—Estradiol—osteoporosis	0.000911	0.00146	CcSEcCtD
Amsacrine—Vomiting—Etidronic acid—osteoporosis	0.00091	0.00146	CcSEcCtD
Amsacrine—Tachycardia—Pamidronate—osteoporosis	0.000908	0.00146	CcSEcCtD
Amsacrine—Connective tissue disorder—Estradiol—osteoporosis	0.000906	0.00146	CcSEcCtD
Amsacrine—Urethral disorder—Estradiol—osteoporosis	0.000904	0.00145	CcSEcCtD
Amsacrine—Rash—Etidronic acid—osteoporosis	0.000903	0.00145	CcSEcCtD
Amsacrine—Convulsion—Zoledronate—osteoporosis	0.000902	0.00145	CcSEcCtD
Amsacrine—Dermatitis—Etidronic acid—osteoporosis	0.000902	0.00145	CcSEcCtD
Amsacrine—Hypersensitivity—Alendronate—osteoporosis	0.000899	0.00144	CcSEcCtD
Amsacrine—Headache—Etidronic acid—osteoporosis	0.000897	0.00144	CcSEcCtD
Amsacrine—Asthenia—Estropipate—osteoporosis	0.000889	0.00143	CcSEcCtD
Amsacrine—Anorexia—Pamidronate—osteoporosis	0.000887	0.00142	CcSEcCtD
Amsacrine—NCOA3—Metabolism—PKM—osteoporosis	0.000881	0.00656	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—FDPS—osteoporosis	0.000881	0.00656	CbGpPWpGaD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000881	0.00141	CcSEcCtD
Amsacrine—Paraesthesia—Risedronate—osteoporosis	0.000879	0.00141	CcSEcCtD
Amsacrine—Asthenia—Alendronate—osteoporosis	0.000875	0.00141	CcSEcCtD
Amsacrine—Hypersensitivity—Ibandronate—osteoporosis	0.000875	0.00141	CcSEcCtD
Amsacrine—Dyspnoea—Risedronate—osteoporosis	0.000873	0.0014	CcSEcCtD
Amsacrine—Hypotension—Pamidronate—osteoporosis	0.00087	0.0014	CcSEcCtD
Amsacrine—Convulsion—Conjugated Estrogens—osteoporosis	0.000869	0.0014	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000867	0.00139	CcSEcCtD
Amsacrine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000866	0.00139	CcSEcCtD
Amsacrine—Confusional state—Zoledronate—osteoporosis	0.000857	0.00138	CcSEcCtD
Amsacrine—Hypersensitivity—Calcitriol—osteoporosis	0.000857	0.00138	CcSEcCtD
Amsacrine—Cardiac disorder—Estradiol—osteoporosis	0.000856	0.00137	CcSEcCtD
Amsacrine—Asthenia—Ibandronate—osteoporosis	0.000852	0.00137	CcSEcCtD
Amsacrine—Nausea—Etidronic acid—osteoporosis	0.00085	0.00137	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000848	0.00136	CcSEcCtD
Amsacrine—Diarrhoea—Estropipate—osteoporosis	0.000847	0.00136	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000845	0.00136	CcSEcCtD
Amsacrine—Infection—Zoledronate—osteoporosis	0.000844	0.00136	CcSEcCtD
Amsacrine—Fatigue—Risedronate—osteoporosis	0.000844	0.00136	CcSEcCtD
Amsacrine—Pain—Risedronate—osteoporosis	0.000837	0.00134	CcSEcCtD
Amsacrine—Angiopathy—Estradiol—osteoporosis	0.000836	0.00134	CcSEcCtD
Amsacrine—Paraesthesia—Pamidronate—osteoporosis	0.000836	0.00134	CcSEcCtD
Amsacrine—NCOA3—Metabolism—GPD2—osteoporosis	0.000835	0.00622	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PGLS—osteoporosis	0.000835	0.00622	CbGpPWpGaD
Amsacrine—Diarrhoea—Alendronate—osteoporosis	0.000835	0.00134	CcSEcCtD
Amsacrine—Asthenia—Calcitriol—osteoporosis	0.000834	0.00134	CcSEcCtD
Amsacrine—Thrombocytopenia—Zoledronate—osteoporosis	0.000832	0.00134	CcSEcCtD
Amsacrine—Mediastinal disorder—Estradiol—osteoporosis	0.000831	0.00133	CcSEcCtD
Amsacrine—Dyspnoea—Pamidronate—osteoporosis	0.00083	0.00133	CcSEcCtD
Amsacrine—Tachycardia—Zoledronate—osteoporosis	0.00083	0.00133	CcSEcCtD
Amsacrine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000827	0.00133	CcSEcCtD
Amsacrine—Skin disorder—Zoledronate—osteoporosis	0.000826	0.00133	CcSEcCtD
Amsacrine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000821	0.00132	CcSEcCtD
Amsacrine—Diarrhoea—Raloxifene—osteoporosis	0.000821	0.00132	CcSEcCtD
Amsacrine—Dizziness—Estropipate—osteoporosis	0.000819	0.00132	CcSEcCtD
Amsacrine—Alopecia—Estradiol—osteoporosis	0.000815	0.00131	CcSEcCtD
Amsacrine—Infection—Conjugated Estrogens—osteoporosis	0.000813	0.00131	CcSEcCtD
Amsacrine—Diarrhoea—Ibandronate—osteoporosis	0.000813	0.00131	CcSEcCtD
Amsacrine—Anorexia—Zoledronate—osteoporosis	0.00081	0.0013	CcSEcCtD
Amsacrine—Decreased appetite—Pamidronate—osteoporosis	0.000809	0.0013	CcSEcCtD
Amsacrine—Mental disorder—Estradiol—osteoporosis	0.000808	0.0013	CcSEcCtD
Amsacrine—Dizziness—Alendronate—osteoporosis	0.000807	0.0013	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000803	0.00129	CcSEcCtD
Amsacrine—Malnutrition—Estradiol—osteoporosis	0.000803	0.00129	CcSEcCtD
Amsacrine—Fatigue—Pamidronate—osteoporosis	0.000802	0.00129	CcSEcCtD
Amsacrine—Gastrointestinal pain—Risedronate—osteoporosis	0.0008	0.00129	CcSEcCtD
Amsacrine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000799	0.00128	CcSEcCtD
Amsacrine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000798	0.00128	CcSEcCtD
Amsacrine—Pain—Pamidronate—osteoporosis	0.000796	0.00128	CcSEcCtD
Amsacrine—Diarrhoea—Calcitriol—osteoporosis	0.000796	0.00128	CcSEcCtD
Amsacrine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000795	0.00128	CcSEcCtD
Amsacrine—Hypotension—Zoledronate—osteoporosis	0.000794	0.00128	CcSEcCtD
Amsacrine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000794	0.00127	CcSEcCtD
Amsacrine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000794	0.00127	CcSEcCtD
Amsacrine—Dizziness—Raloxifene—osteoporosis	0.000793	0.00127	CcSEcCtD
Amsacrine—Vomiting—Estropipate—osteoporosis	0.000788	0.00126	CcSEcCtD
Amsacrine—Dizziness—Ibandronate—osteoporosis	0.000785	0.00126	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000784	0.00584	CbGpPWpGaD
Amsacrine—Rash—Estropipate—osteoporosis	0.000781	0.00125	CcSEcCtD
Amsacrine—Dermatitis—Estropipate—osteoporosis	0.00078	0.00125	CcSEcCtD
Amsacrine—Anorexia—Conjugated Estrogens—osteoporosis	0.00078	0.00125	CcSEcCtD
Amsacrine—Urticaria—Risedronate—osteoporosis	0.000778	0.00125	CcSEcCtD
Amsacrine—Headache—Estropipate—osteoporosis	0.000776	0.00125	CcSEcCtD
Amsacrine—Vomiting—Alendronate—osteoporosis	0.000776	0.00125	CcSEcCtD
Amsacrine—Abdominal pain—Risedronate—osteoporosis	0.000774	0.00124	CcSEcCtD
Amsacrine—Body temperature increased—Risedronate—osteoporosis	0.000774	0.00124	CcSEcCtD
Amsacrine—Rash—Alendronate—osteoporosis	0.000769	0.00124	CcSEcCtD
Amsacrine—Dermatitis—Alendronate—osteoporosis	0.000769	0.00123	CcSEcCtD
Amsacrine—Feeling abnormal—Pamidronate—osteoporosis	0.000767	0.00123	CcSEcCtD
Amsacrine—Hypotension—Conjugated Estrogens—osteoporosis	0.000765	0.00123	CcSEcCtD
Amsacrine—Headache—Alendronate—osteoporosis	0.000764	0.00123	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ATIC—osteoporosis	0.000764	0.00569	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PNP—osteoporosis	0.000764	0.00569	CbGpPWpGaD
Amsacrine—Paraesthesia—Zoledronate—osteoporosis	0.000763	0.00123	CcSEcCtD
Amsacrine—Vomiting—Raloxifene—osteoporosis	0.000763	0.00123	CcSEcCtD
Amsacrine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000761	0.00122	CcSEcCtD
Amsacrine—Dyspnoea—Zoledronate—osteoporosis	0.000758	0.00122	CcSEcCtD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000758	0.00564	CbGpPWpGaD
Amsacrine—Rash—Raloxifene—osteoporosis	0.000757	0.00121	CcSEcCtD
Amsacrine—Dermatitis—Raloxifene—osteoporosis	0.000756	0.00121	CcSEcCtD
Amsacrine—Vomiting—Ibandronate—osteoporosis	0.000755	0.00121	CcSEcCtD
Amsacrine—Headache—Raloxifene—osteoporosis	0.000752	0.00121	CcSEcCtD
Amsacrine—Rash—Ibandronate—osteoporosis	0.000749	0.0012	CcSEcCtD
Amsacrine—Dermatitis—Ibandronate—osteoporosis	0.000748	0.0012	CcSEcCtD
Amsacrine—Headache—Ibandronate—osteoporosis	0.000744	0.0012	CcSEcCtD
Amsacrine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00074	0.00119	CcSEcCtD
Amsacrine—Vomiting—Calcitriol—osteoporosis	0.000739	0.00119	CcSEcCtD
Amsacrine—Decreased appetite—Zoledronate—osteoporosis	0.000739	0.00119	CcSEcCtD
Amsacrine—Nausea—Estropipate—osteoporosis	0.000736	0.00118	CcSEcCtD
Amsacrine—Body temperature increased—Pamidronate—osteoporosis	0.000736	0.00118	CcSEcCtD
Amsacrine—Abdominal pain—Pamidronate—osteoporosis	0.000736	0.00118	CcSEcCtD
Amsacrine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000735	0.00118	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000734	0.00118	CcSEcCtD
Amsacrine—Rash—Calcitriol—osteoporosis	0.000733	0.00118	CcSEcCtD
Amsacrine—Fatigue—Zoledronate—osteoporosis	0.000733	0.00118	CcSEcCtD
Amsacrine—Dermatitis—Calcitriol—osteoporosis	0.000732	0.00118	CcSEcCtD
Amsacrine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00073	0.00117	CcSEcCtD
Amsacrine—Headache—Calcitriol—osteoporosis	0.000728	0.00117	CcSEcCtD
Amsacrine—Pain—Zoledronate—osteoporosis	0.000727	0.00117	CcSEcCtD
Amsacrine—Nausea—Alendronate—osteoporosis	0.000725	0.00116	CcSEcCtD
Amsacrine—Hypersensitivity—Risedronate—osteoporosis	0.000721	0.00116	CcSEcCtD
Amsacrine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00072	0.00116	CcSEcCtD
Amsacrine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000717	0.00534	CbGpPWpGaD
Amsacrine—Nausea—Raloxifene—osteoporosis	0.000713	0.00114	CcSEcCtD
Amsacrine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000711	0.00114	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000707	0.00113	CcSEcCtD
Amsacrine—Fatigue—Conjugated Estrogens—osteoporosis	0.000706	0.00113	CcSEcCtD
Amsacrine—Nausea—Ibandronate—osteoporosis	0.000706	0.00113	CcSEcCtD
Amsacrine—Asthenia—Risedronate—osteoporosis	0.000702	0.00113	CcSEcCtD
Amsacrine—Feeling abnormal—Zoledronate—osteoporosis	0.0007	0.00112	CcSEcCtD
Amsacrine—Pain—Conjugated Estrogens—osteoporosis	0.0007	0.00112	CcSEcCtD
Amsacrine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000695	0.00112	CcSEcCtD
Amsacrine—Nausea—Calcitriol—osteoporosis	0.000691	0.00111	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.00069	0.00514	CbGpPWpGaD
Amsacrine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000687	0.0011	CcSEcCtD
Amsacrine—Hypersensitivity—Pamidronate—osteoporosis	0.000686	0.0011	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000679	0.00109	CcSEcCtD
Amsacrine—Urticaria—Zoledronate—osteoporosis	0.000675	0.00108	CcSEcCtD
Amsacrine—Abdominal pain—Zoledronate—osteoporosis	0.000672	0.00108	CcSEcCtD
Amsacrine—Body temperature increased—Zoledronate—osteoporosis	0.000672	0.00108	CcSEcCtD
Amsacrine—Diarrhoea—Risedronate—osteoporosis	0.00067	0.00108	CcSEcCtD
Amsacrine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000669	0.00107	CcSEcCtD
Amsacrine—Asthenia—Pamidronate—osteoporosis	0.000668	0.00107	CcSEcCtD
Amsacrine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000664	0.00107	CcSEcCtD
Amsacrine—Confusional state—Estradiol—osteoporosis	0.00066	0.00106	CcSEcCtD
Amsacrine—Infection—Estradiol—osteoporosis	0.000651	0.00105	CcSEcCtD
Amsacrine—Urticaria—Conjugated Estrogens—osteoporosis	0.00065	0.00104	CcSEcCtD
Amsacrine—NCOA3—Metabolism—OXCT1—osteoporosis	0.000649	0.00484	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CA2—osteoporosis	0.000649	0.00484	CbGpPWpGaD
Amsacrine—Dizziness—Risedronate—osteoporosis	0.000647	0.00104	CcSEcCtD
Amsacrine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000647	0.00104	CcSEcCtD
Amsacrine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000647	0.00104	CcSEcCtD
Amsacrine—Tachycardia—Estradiol—osteoporosis	0.000639	0.00103	CcSEcCtD
Amsacrine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000638	0.00103	CcSEcCtD
Amsacrine—Diarrhoea—Pamidronate—osteoporosis	0.000637	0.00102	CcSEcCtD
Amsacrine—Skin disorder—Estradiol—osteoporosis	0.000636	0.00102	CcSEcCtD
Amsacrine—Rash—Ethinyl Estradiol—osteoporosis	0.000633	0.00102	CcSEcCtD
Amsacrine—NCOA3—Metabolism—MGLL—osteoporosis	0.000633	0.00471	CbGpPWpGaD
Amsacrine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000632	0.00102	CcSEcCtD
Amsacrine—Headache—Ethinyl Estradiol—osteoporosis	0.000629	0.00101	CcSEcCtD
Amsacrine—Hypersensitivity—Zoledronate—osteoporosis	0.000626	0.00101	CcSEcCtD
Amsacrine—Vomiting—Risedronate—osteoporosis	0.000622	0.001	CcSEcCtD
Amsacrine—Rash—Risedronate—osteoporosis	0.000617	0.000991	CcSEcCtD
Amsacrine—Dermatitis—Risedronate—osteoporosis	0.000617	0.00099	CcSEcCtD
Amsacrine—Dizziness—Pamidronate—osteoporosis	0.000615	0.000988	CcSEcCtD
Amsacrine—Headache—Risedronate—osteoporosis	0.000613	0.000985	CcSEcCtD
Amsacrine—Asthenia—Zoledronate—osteoporosis	0.00061	0.000979	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000604	0.0045	CbGpPWpGaD
Amsacrine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000603	0.000968	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—MYC—osteoporosis	0.000599	0.00446	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000597	0.00444	CbGpPWpGaD
Amsacrine—Nausea—Ethinyl Estradiol—osteoporosis	0.000596	0.000958	CcSEcCtD
Amsacrine—Vomiting—Pamidronate—osteoporosis	0.000592	0.00095	CcSEcCtD
Amsacrine—Paraesthesia—Estradiol—osteoporosis	0.000588	0.000945	CcSEcCtD
Amsacrine—Asthenia—Conjugated Estrogens—osteoporosis	0.000587	0.000943	CcSEcCtD
Amsacrine—Rash—Pamidronate—osteoporosis	0.000587	0.000942	CcSEcCtD
Amsacrine—Dermatitis—Pamidronate—osteoporosis	0.000586	0.000941	CcSEcCtD
Amsacrine—Dyspnoea—Estradiol—osteoporosis	0.000584	0.000938	CcSEcCtD
Amsacrine—Headache—Pamidronate—osteoporosis	0.000583	0.000936	CcSEcCtD
Amsacrine—Diarrhoea—Zoledronate—osteoporosis	0.000582	0.000934	CcSEcCtD
Amsacrine—Nausea—Risedronate—osteoporosis	0.000581	0.000934	CcSEcCtD
Amsacrine—Decreased appetite—Estradiol—osteoporosis	0.000569	0.000914	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000566	0.000908	CcSEcCtD
Amsacrine—Fatigue—Estradiol—osteoporosis	0.000565	0.000907	CcSEcCtD
Amsacrine—Dizziness—Zoledronate—osteoporosis	0.000562	0.000903	CcSEcCtD
Amsacrine—Pain—Estradiol—osteoporosis	0.00056	0.0009	CcSEcCtD
Amsacrine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00056	0.000899	CcSEcCtD
Amsacrine—Nausea—Pamidronate—osteoporosis	0.000553	0.000888	CcSEcCtD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—osteoporosis	0.000552	0.00411	CbGpPWpGaD
Amsacrine—Dizziness—Conjugated Estrogens—osteoporosis	0.000541	0.000869	CcSEcCtD
Amsacrine—Vomiting—Zoledronate—osteoporosis	0.00054	0.000868	CcSEcCtD
Amsacrine—Feeling abnormal—Estradiol—osteoporosis	0.00054	0.000867	CcSEcCtD
Amsacrine—NCOA3—Metabolism—IDH2—osteoporosis	0.000538	0.00401	CbGpPWpGaD
Amsacrine—Rash—Zoledronate—osteoporosis	0.000536	0.000861	CcSEcCtD
Amsacrine—Gastrointestinal pain—Estradiol—osteoporosis	0.000536	0.00086	CcSEcCtD
Amsacrine—Dermatitis—Zoledronate—osteoporosis	0.000535	0.00086	CcSEcCtD
Amsacrine—Headache—Zoledronate—osteoporosis	0.000532	0.000855	CcSEcCtD
Amsacrine—Vomiting—Conjugated Estrogens—osteoporosis	0.00052	0.000836	CcSEcCtD
Amsacrine—Urticaria—Estradiol—osteoporosis	0.00052	0.000836	CcSEcCtD
Amsacrine—Abdominal pain—Estradiol—osteoporosis	0.000518	0.000832	CcSEcCtD
Amsacrine—Body temperature increased—Estradiol—osteoporosis	0.000518	0.000832	CcSEcCtD
Amsacrine—Rash—Conjugated Estrogens—osteoporosis	0.000516	0.000829	CcSEcCtD
Amsacrine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000516	0.000828	CcSEcCtD
Amsacrine—Headache—Conjugated Estrogens—osteoporosis	0.000513	0.000823	CcSEcCtD
Amsacrine—NCOA3—Metabolism—CYP27A1—osteoporosis	0.000506	0.00377	CbGpPWpGaD
Amsacrine—Nausea—Zoledronate—osteoporosis	0.000505	0.000811	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ACP5—osteoporosis	0.000492	0.00367	CbGpPWpGaD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000491	0.00366	CbGpPWpGaD
Amsacrine—Nausea—Conjugated Estrogens—osteoporosis	0.000486	0.000781	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000486	0.00362	CbGpPWpGaD
Amsacrine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000485	0.00361	CbGpPWpGaD
Amsacrine—Hypersensitivity—Estradiol—osteoporosis	0.000483	0.000775	CcSEcCtD
Amsacrine—Asthenia—Estradiol—osteoporosis	0.00047	0.000755	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—LEP—osteoporosis	0.000467	0.00348	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—TPI1—osteoporosis	0.000458	0.00341	CbGpPWpGaD
Amsacrine—Diarrhoea—Estradiol—osteoporosis	0.000448	0.00072	CcSEcCtD
Amsacrine—Dizziness—Estradiol—osteoporosis	0.000433	0.000696	CcSEcCtD
Amsacrine—NCOA3—Metabolism—P4HB—osteoporosis	0.00043	0.0032	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GAPDH—osteoporosis	0.000422	0.00314	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—LEP—osteoporosis	0.000421	0.00313	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000418	0.00312	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000417	0.00311	CbGpPWpGaD
Amsacrine—Vomiting—Estradiol—osteoporosis	0.000416	0.000669	CcSEcCtD
Amsacrine—Rash—Estradiol—osteoporosis	0.000413	0.000663	CcSEcCtD
Amsacrine—Dermatitis—Estradiol—osteoporosis	0.000413	0.000663	CcSEcCtD
Amsacrine—NCOA3—Metabolism—RAP1A—osteoporosis	0.000411	0.00306	CbGpPWpGaD
Amsacrine—Headache—Estradiol—osteoporosis	0.00041	0.000659	CcSEcCtD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000408	0.00304	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	0.000402	0.003	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000398	0.00296	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	0.000397	0.00296	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—IL6R—osteoporosis	0.000392	0.00292	CbGpPWpGaD
Amsacrine—Nausea—Estradiol—osteoporosis	0.000389	0.000625	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000374	0.00278	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000374	0.00278	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—ADCY5—osteoporosis	0.000365	0.00272	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000362	0.0027	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000359	0.00267	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000338	0.00252	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—PSMA2—osteoporosis	0.000334	0.00249	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—PSMA5—osteoporosis	0.000334	0.00249	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ENO1—osteoporosis	0.000332	0.00248	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PSMA2—osteoporosis	0.000328	0.00244	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PSMA5—osteoporosis	0.000328	0.00244	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000319	0.00238	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000317	0.00236	CbGpPWpGaD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000295	0.0022	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000287	0.00214	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP19A1—osteoporosis	0.000266	0.00198	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000239	0.00178	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TGFB1—osteoporosis	0.000232	0.00172	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TNF—osteoporosis	0.00023	0.00171	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000227	0.00169	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000218	0.00162	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ADCY5—osteoporosis	0.000217	0.00162	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000217	0.00162	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GPX1—osteoporosis	0.000216	0.00161	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TNF—osteoporosis	0.000216	0.00161	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	0.000213	0.00159	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	0.000211	0.00157	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	0.000209	0.00155	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000203	0.00151	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MTHFR—osteoporosis	0.0002	0.00149	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL1B—osteoporosis	0.000186	0.00139	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000186	0.00138	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000178	0.00133	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—IL6—osteoporosis	0.000175	0.0013	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—POMC—osteoporosis	0.00016	0.00119	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—osteoporosis	0.000157	0.00117	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	0.000145	0.00108	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000138	0.00103	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TNF—osteoporosis	0.000135	0.00101	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PKM—osteoporosis	0.000127	0.000947	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—FDPS—osteoporosis	0.000127	0.000947	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—POMC—osteoporosis	0.000127	0.000946	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PGLS—osteoporosis	0.000121	0.000898	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPD2—osteoporosis	0.000121	0.000898	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—FDPS—osteoporosis	0.00012	0.000893	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PKM—osteoporosis	0.00012	0.000893	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000119	0.000888	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PGLS—osteoporosis	0.000114	0.000846	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPD2—osteoporosis	0.000114	0.000846	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ATIC—osteoporosis	0.00011	0.000821	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PNP—osteoporosis	0.00011	0.000821	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—osteoporosis	0.000105	0.000785	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PNP—osteoporosis	0.000104	0.000774	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ATIC—osteoporosis	0.000104	0.000774	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MYC—osteoporosis	9.42e-05	0.000702	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CA2—osteoporosis	9.38e-05	0.000698	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—OXCT1—osteoporosis	9.38e-05	0.000698	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MGLL—osteoporosis	9.14e-05	0.00068	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—OXCT1—osteoporosis	8.83e-05	0.000658	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CA2—osteoporosis	8.83e-05	0.000658	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MGLL—osteoporosis	8.61e-05	0.000641	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—IDH2—osteoporosis	7.77e-05	0.000579	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—IDH2—osteoporosis	7.32e-05	0.000545	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP27A1—osteoporosis	7.3e-05	0.000544	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	7.17e-05	0.000534	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	7.15e-05	0.000533	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ACP5—osteoporosis	7.11e-05	0.000529	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP27A1—osteoporosis	6.88e-05	0.000513	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ACP5—osteoporosis	6.7e-05	0.000499	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.69e-05	0.000498	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.68e-05	0.000497	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TPI1—osteoporosis	6.61e-05	0.000492	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TPI1—osteoporosis	6.22e-05	0.000464	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—P4HB—osteoporosis	6.21e-05	0.000463	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GAPDH—osteoporosis	6.1e-05	0.000454	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—RAP1A—osteoporosis	5.94e-05	0.000442	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—P4HB—osteoporosis	5.85e-05	0.000436	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GAPDH—osteoporosis	5.74e-05	0.000428	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—RAP1A—osteoporosis	5.59e-05	0.000417	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ENO1—osteoporosis	4.8e-05	0.000357	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PSMA5—osteoporosis	4.73e-05	0.000352	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PSMA2—osteoporosis	4.73e-05	0.000352	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ENO1—osteoporosis	4.52e-05	0.000337	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PSMA2—osteoporosis	4.46e-05	0.000332	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PSMA5—osteoporosis	4.46e-05	0.000332	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP19A1—osteoporosis	3.84e-05	0.000286	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP19A1—osteoporosis	3.62e-05	0.000269	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ADCY5—osteoporosis	3.13e-05	0.000233	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPX1—osteoporosis	3.12e-05	0.000233	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ADCY5—osteoporosis	2.95e-05	0.00022	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPX1—osteoporosis	2.94e-05	0.000219	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTHFR—osteoporosis	2.88e-05	0.000215	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTHFR—osteoporosis	2.72e-05	0.000202	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—POMC—osteoporosis	2.31e-05	0.000172	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—POMC—osteoporosis	2.17e-05	0.000162	CbGpPWpGaD
